Encorafenib

康奈非尼

CAS1269440-17-6

用途分类

医药原料药

化合物类别

杂环

主要用途

医药原料

Encorafenib is a small molecule compound that functions as a BRAF inhibitor, targeting key enzymes in the MAPK signaling pathway. It is supplied as a pharmaceutical raw material for use in research and manufacturing of cancer therapies.

Pharmaceutical manufacturingResearch compound for MAPK pathway studiesAPI for melanoma drug formulations

内容范围: 本页信息面向化学品识别与工业供应、研发、生产场景，不构成疗效宣称、医疗建议或药品使用指导。

需要采购Encorafenib？

免费发布采购需求，无需注册。需求会推送给能供应该产品的供应商，回复直达你的邮箱。

发布采购需求是供应商？为该 CAS 上架产品

安全参考

健康危害

环境危害

危险

H351Suspected of causing cancer

H360May damage fertility or the unborn child

H361Suspected of damaging fertility or the unborn child

H372Causes damage to organs through prolonged or repeated exposure

H373May cause damage to organs through prolonged or repeated exposure

H400Very toxic to aquatic life

H411Toxic to aquatic life with long lasting effects

海关税则归类

Encorafenib(CAS 1269440-17-6)的国际 HS 编码为 2935.90。

HS 编码(国际通用,6 位)

2935.90

欧盟 CN 编码(8 位)

2935 90 90

归类依据欧盟海关化学品目录 ECICS(2026-07 快照,HS 2022 版)。各国税则细目及产品形态可能影响最终归类。

标识符

IUPAC 名称

methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate

InChIKey

CMJCXYNUCSMDBY-ZDUSSCGKSA-N

SMILES

C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC

别名列表 (21)

Encorafenib (JAN/USAN/INN)
Braftovi
Braftovi (TN)
Encorafenib
Encorafenib (LGX818)
Encorafenib (Standard)
Encorafenib Refrence standard
LGX-818(Encorafenib)
LY2606368 mesylate
US9314464, 9
encorafenibum